Notice of NHLBI's participation on PAR-17-450 "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)"

Notice Number: NOT-HL-17-535

Key Dates
Release Date: August 17, 2017

Related Announcements
PAR-17-450

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating is participating in PAR-17-450, "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)."

The following changes have been made to reflect NCI's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Cancer Institute (NCI)
National Institute of Nursing Research (NINR)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s) 
93.113; 93.847; 93.398; 93.361 93.837, 93.838, 93.839, 93.840, 93.233

Part 2. Full Text of Announcement

Section VII. Agency Contacts
The following contacts have been added:

Scientific/Research Contacts
Robert Balaban
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-496-2116
Email: balabanr@nhlbi.nih.gov

Richard Childs
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-451-7128
Email: childsr@nhlbi.nih.gov

Financial/Grants Management Contact(s)
Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0186
Email: agrestia@nhlbi.nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Dana A. Phares, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7968
Email: pharesda@nhlbi.nih.gov